In addition external validation by an independent larger cohort was not conducted in stage III but up to now CRP at base line was also analyzed so far in oligometastatic NSCLC patients treated with thoracic radiochemotherapy and found to be prognostic22. Here, CRP is linked to non-small cell lung carcinoma.